
News|Articles|September 1, 2004
New molecular entity: Duloxetine
SSNRI approved for the treatment of major depressive disorder
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























